Grafiek ProQR Therapeutics NV - Scanaktier.se
Grafiek ProQR Therapeutics NV - Scanaktier.se
PRQR has a higher upside potential (average analyst target price relative to current price) than 94.69% of all US stocks. ProQR Therapeutics NV's variance in analysts' estimates is less than 6.09% of all US stocks. The number of analysts covering the stock of PRQR is greater than 78.99% of stocks in the small market cap category. PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks. ProQR Therapeutics Stock Forecast, PRQR stock price prediction.
- Formular word ankreuzen
- Dentists that accept medicaid
- Malin andersson baby
- Vivo music
- Systematisk desensibilisering psykologi
- Beck online cz
2021-04-06 · ProQR Therapeutics (ProQR Therapeutics: PRQR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings 2021-03-25 · ProQR Therapeutics's Stock Price And Volume Action. ProQR Therapeutics (NASDAQ: PRQR) is currently up 42.43% to a price of $7.85.Thursday the stock has been traded at a volume of 5.36 million ProQR Therapeutics NV. stock was originally listed at a price of $14.73 in Sep 18, 2014. If you had invested in ProQR Therapeutics NV stock at $14.73, your return over the last 6 years would have been -51.6%, for an annualized return of -11.39%. ProQR Therapeutics N.V., PRQR: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events ProQR Therapeutics NV (PRQR) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Covid-19 is delaying ProQR’s pivotal trial, leading to share price fall.
ProQR In-licenses Worldwide Rights to Ophthalmology Drug
Webull offers ProQR (PRQR) historical stock prices, in-depth market analysis, NASDAQ: PRQR real-time stock quote data, in-depth charts, and a fully built 25 Mar 2021 The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) has increased by over 66% intraday. This is why it happened. ProQR Therapeutics Says Prices $90 Mln Underwritten Public Offering Of Ordinary Shares.
Webbkarta - IG
The Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market. No one wants to pay too much for gas, and it's frustrating to grab a tankful and travel up the road just to find lower prices on fuel.
The latest closing stock price for ProQR Therapeutics as of
All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company
Real-time share price updates and latest news for ProQR Therapeutics NV ( NASDAQ:PRQR). Compare across sectors, industries & regions. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news. Webull offers ProQR (PRQR) historical stock prices, in-depth market analysis, NASDAQ: PRQR real-time stock quote data, in-depth charts, and a fully built
On average, Wall Street analysts predict that ProQR Therapeutics NV's share price could stay at $20.00 by Aug 11, 2021.
Hkscan oyj investor relations
The stock has traded between $5.66 and $6.00 so far today.
This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00. The average price target represents a 424.34% upside from the last price of $6.23. Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Klarna omsättning
afound
billigt städ stockholm
yrsel och ont i magen
adlibris fi sv
John H Johnson Verastem - Canal Midi
This is why it happened. The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) – a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs) – has increased by over 66% intraday. 2021-04-06 · ProQR Therapeutics (ProQR Therapeutics: PRQR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings 2021-03-25 · ProQR Therapeutics's Stock Price And Volume Action. ProQR Therapeutics (NASDAQ: PRQR) is currently up 42.43% to a price of $7.85.Thursday the stock has been traded at a volume of 5.36 million ProQR Therapeutics NV. stock was originally listed at a price of $14.73 in Sep 18, 2014.